We found that the mRNA level of NALCN was underexpressed in 12 of 22 (54.5%), NSCLC tissues as the expression of NALCN was reduced in tumor samples comparedto the corresponding adjacent tissue. This evidence concerns the gene NALCN and non-small cell lung carcinoma.